NPM1 and acute myeloid leukemia: At the other end of the spectrum are highly recurrent fusions and mutations, exemplified by the RUNX1-RUNX1T1 fusion (89) and exon 12 mutations in nucleophosmin1 (NPM1) (102, 103) in AML.